#news #biotech Gilead’s long-term R&D lead Bischofberger steps down

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gilead’s long-term R&D lead Bischofberger steps down .Gilead’s long-serving Norbert Bischofberger, Ph.D, is stepping down as EVP of R&D and its chief scientific officer this April, as it promotes John McHutchison, M.D., to the top job.

from FierceBiotech: Biotech http://ift.tt/2FJSlmf